7.73
+0.08
(1.05%)
May 17 - Close
SHA
real-time data -
Disclaimer
Currency in CNY
| Range | 7.55 - 7.84 |
| 52 week | 5.40 - 7.87 |
| Open | 7.63 |
| Vol. | 27.91M |
| Mkt cap | 14.82B |
| P/E | - |
| EPS | -0.03 |
| Shares | 1.92B |
Events
Jun 28, 2013
Harbin Pharmaceutical Group Co Ltd Annual Shareholder Meeting
May 11, 2013
哈药股份：发行股份购买资产暨关联交易之持续督导工作报告书
Apr 27, 2013
哈药股份：关于公司2012年度控股股东及其他关联方资金占用情况汇总表的专项说明
Apr 27, 2013
哈药股份：关于公司盈利预测实现情况的专项审核报告
Apr 27, 2013
哈药股份：关于公司对外担保情况的专项说明及独立董事意见
Apr 27, 2013
哈药股份：关于2013年日常关联交易预计的公告
Apr 27, 2013
哈药股份：2012年年度报告
Apr 27, 2013
哈药股份：2012年度独立董事述职报告
Apr 27, 2013
哈药股份：2012年年度报告摘要
Apr 27, 2013
哈药股份：2013年第一季度报告
|
|
Key stats and ratios
| Q4 (Dec '12) | 2012 | |
| Net profit margin | 5.76% | 3.34% |
| Operating margin | 6.08% | 5.15% |
| EBITD margin | - | 8.14% |
| Return on average assets | 6.22% | 3.79% |
| Return on average equity | 10.85% | 6.50% |
| Employees | 16,336 | - |
| Carbon Disclosure Rating | - | - |
Address
No.1 Qunli Avenue, Qunli New District
HAERBIN, HNG 150018
China
+86-451-51870077 (Phone)
+86-451-51870277 (Fax)
HAERBIN, HNG 150018
China
+86-451-51870077 (Phone)
+86-451-51870277 (Fax)
Website links
External links
Discussion Group - Google Finance
Advertisement
Description
HARBIN PHARMACEUTICAL GROUP CO.,LTD. is principally engaged in the manufacture and distribution of pharmaceuticals. The Company's major products are antibiotics, Chinese medicines, chemical drugs, over-the-counter (OTC) medicines, healthcare products, biological engineering, animal vaccines and animal remedies, among others, including injections, powder injections, oral liquid, tablets and capsules, among others. The Company distributes its products in domestic and overseas markets.
Officers and directors
| Lijun Zhang | Chairman of the Board, General Manager | |
| Bo Liu | Chief Accounting Officer, Director | |
| Zhijun Wu | Deputy General Manager, Director | |
| Huicheng Li | Chief Engineer | |
| Xiaodong Meng | Secretary of the Board, Deputy General Manager | |
| Benming Li | Director | |
| Zhanbin Liu | Director | |
| Yizhong Wu | Director | |
| Shulan Chen | Independent Director | |
| Fusheng Wang | Independent Director |